Efficacy of mulberry leaf tablets in patients with mild dyslipidemia
- 23 February 2011
- journal article
- clinical trial
- Published by Wiley in Phytotherapy Research
- Vol. 25 (3) , 365-369
Abstract
Mulberry leaf is well known for its several biological effects. The purpose of this study was to evaluate the hypolipidemic effect of mulberry leaf in non‐diabetic patients with mild dyslipidemia. A within‐subjects research design was conducted at the out‐patient clinic in Thailand. Twenty‐three patients who met the NCEP ATP III criteria guideline for dyslipidemia and failed a 4 week diet therapy were enrolled and assigned to receive three tablets of 280 mg mulberry leaf tablet three times a day before meals for a period of 12 weeks. Routine blood analyses including lipid parameters and liver function tests were performed every 4 weeks. At 4 and 8 weeks of mulberry leaf tablet therapy, triglyceride was significantly decreased by 10.2% (p < 0.05) and 12.5% (p < 0.05), respectively, from baseline. At the end of the study, total cholesterol, triglyceride and LDL were significantly decreased by 4.9% (p < 0.05), 14.1% (p < 0.05) and 5.6% (p < 0.05), respectively, from baseline, whereas HDL was significantly increased by 19.7% (p < 0.05). Even though some patients experienced side effects such as mild diarrhea (26%), dizziness (8.7%) or constipation and bloating (4.3%), mulberry leaf tablet therapy is still capable and safe in reducing cholesterol levels and enhancing HDL in patients with mild dyslipidemia. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extractBMC Complementary and Alternative Medicine, 2007
- Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient miceBiochemical and Biophysical Research Communications, 2007
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterolThe Journal of Nutritional Biochemistry, 2004
- Quercetin Dihydrate and Gallate Supplements Lower Plasma and Hepatic Lipids and Change Activities of Hepatic Antioxidant Enzymes in High Cholesterol-Fed RatsInternational Journal for Vitamin and Nutrition Research, 2002
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Antithrombogenic and Antiatherogenic Effects of Citrus Flavonoids1998
- Soluble fiber and serum lipids: A literature reviewJournal of the American Dietetic Association, 1994
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986